[HTML][HTML] Diagnostic accuracy of elastography and magnetic resonance imaging in patients with NAFLD: a systematic review and meta-analysis

EA Selvaraj, FE Mózes, ANA Jayaswal… - Journal of …, 2021 - Elsevier
Background and Aims Vibration-controlled transient elastography (VCTE), point shear wave
elastography (pSWE), 2-dimensional shear wave elastography (2DSWE), magnetic …

Nonalcoholic fatty liver disease as a metabolic disease in humans: A literature review

B Cariou, CD Byrne, R Loomba… - Diabetes, Obesity and …, 2021 - Wiley Online Library
Aims To conduct a systematic literature review to identify recent epidemiological, biomarker,
genetic and clinical evidence that expands our understanding of nonalcoholic fatty liver …

Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD: an individual patient data meta-analysis

FE Mózes, JA Lee, EA Selvaraj, ANA Jayaswal… - Gut, 2022 - gut.bmj.com
Objective Liver biopsy is still needed for fibrosis staging in many patients with non-alcoholic
fatty liver disease. The aims of this study were to evaluate the individual diagnostic …

Intestine farnesoid X receptor agonist and the gut microbiota activate G‐protein bile acid receptor‐1 signaling to improve metabolism

P Pathak, C Xie, RG Nichols, JM Ferrell… - …, 2018 - Wiley Online Library
Bile acids activate farnesoid X receptor (FXR) and G protein–coupled bile acid receptor‐1
(aka Takeda G protein–coupled receptor‐5 [TGR5]) to regulate bile acid metabolism and …

Accuracy of controlled attenuation parameter (CAP) and liver stiffness measurement (LSM) for assessing steatosis and fibrosis in non-alcoholic fatty liver disease: A …

Y Cao, L Xiang, F Qi, Y Zhang, Y Chen, X Zhou - EClinicalMedicine, 2022 - thelancet.com
Background Non-alcoholic fatty liver disease (NAFLD) is a common chronic liver disease,
and among the non-invasive tests, controlled attenuation parameter (CAP) and liver stiffness …

Advances in non-invasive assessment of hepatic fibrosis

R Loomba, LA Adams - Gut, 2020 - gut.bmj.com
Liver fibrosis should be assessed in all individuals with chronic liver disease as it predicts
the risk of future liver-related morbidity and thus need for treatment, monitoring and …

Non-invasive diagnosis and biomarkers in alcohol-related liver disease

C Moreno, S Mueller, G Szabo - Journal of hepatology, 2019 - Elsevier
Even though alcohol-related liver disease (ALD) is a major cause of severe liver disease
worldwide, most patients with ALD are diagnosed at the decompensation stage. Liver biopsy …

A randomised controlled trial on the effectiveness and adherence of modified alternate-day calorie restriction in improving activity of non-alcoholic fatty liver disease

MI Johari, K Yusoff, J Haron, C Nadarajan… - Scientific reports, 2019 - nature.com
Currently, there is no effective therapy for non-alcoholic fatty liver disease (NAFLD), and
although calorie restriction is recommended in guidelines, but adherence is an issue. The …

VEGF signaling in neurological disorders

JW Shim, JR Madsen - International journal of molecular sciences, 2018 - mdpi.com
Vascular endothelial growth factor (VEGF) is a potent growth factor playing diverse roles in
vasculogenesis and angiogenesis. In the brain, VEGF mediates angiogenesis, neural …

Prospective comparison of transient, point shear wave, and magnetic resonance elastography for staging liver fibrosis

T Lefebvre, C Wartelle-Bladou, P Wong… - European …, 2019 - Springer
Objectives To perform head-to-head comparisons of the feasibility and diagnostic
performance of transient elastography (TE), point shear-wave elastography (pSWE), and …